An act relating to commercial insurance coverage of epinephrine auto-injectors

This bill requires health insurance plans in Vermont to cover epinephrine auto-injectors without any cost-sharing requirements like deductibles, coinsurance, or copayments when prescribed by a healthcare provider. The law applies to individual and group health insurance policies, hospital service corporations, and health maintenance organizations, but excludes limited benefit plans. Coverage must be provided for plans issued, renewed, or offered on or after January 1, 2025, with a final implementation deadline of January 1, 2026. The legislation aims to ensure immediate access to emergency allergy medication for Vermont residents with health insurance.